Ligand profile
ZINC4830848
Virtual-screening candidate from ZINC.
Bound to: VK055_5132 — AMP nucleosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4830848- UniProt (similar protein)
P0AE12- Tanimoto
- 0.500
- Target protein
- VK055_5132
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 164.5
- −1 ≤ LogP ≤ 5 -2.67
- MW ≤ 500 Da 283.2
- LogP ≤ 5 -2.67
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 164.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1c2[nH]nc([C@H]3O[C@@H](CO)[C@@H](O)[C@H]3O)c2nc[n+]1[O-]Nc1c2[nH]nc([C@H]3O[C@@H](CO)[C@@H](O)[C@H]3O)c2nc[n+]1[O-]
InChI=1S/C10H13N5O5/c11-10-6-4(12-2-15(10)19)5(13-14-6)9-8(18)7(17)3(1-16)20-9/h2-3,7-9,16-18H,1,11H2,(H,13,14)/t3-,7+,8+,9+/m0/s1InChI=1S/C10H13N5O5/c11-10-6-4(12-2-15(10)19)5(13-14-6)9-8(18)7(17)3(1-16)20-9/h2-3,7-9,16-18H,1,11H2,(H,13,14)/t3-,7+,8+,9+/m0/s1
HZMOFMRIURBVFZ-DGRLJHMASA-NHZMOFMRIURBVFZ-DGRLJHMASA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- FMP
- Homolog
- P0AE12
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4830848 →
- ZINC ZINC20 ZINC4830848 →
- UniProt UniProt P0AE12 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4830848”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_5132.
ZINC 30
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).